Squarepoint
CLOV icon

Squarepoint’s Clover Health Investments CLOV Stock Holding History

Squarepoint’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-15,000
Closed -$47.3K – 4681
2024
Q4 		$47.3K Buy
+15,000
New +$53.6K ﹤0.01% 4851
2024
Q2 		– Sell
-225,000
Closed -$179K – 4127
2024
Q1 		$179K Buy
+225,000
New +$205K ﹤0.01% 3646

Other funds holding CLOV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Squarepoint's CLOV Position: Q1 2026 in Review

Squarepoint opened a new position in Clover Health Investments (CLOV) in Q1 2026: 112,807 shares worth $199K. The stake represents ﹤0.01% of the portfolio and ranks #3961 among its holdings. This is a return to the name: Squarepoint previously reported a position in CLOV as recently as Q3 2025.

Squarepoint first reported a position in CLOV in Q3 2020 and has held it in 17 quarters since. The position peaked at $2.36M in Q1 2025. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

  • Squarepoint held 112,807 shares of Clover Health Investments worth $199K as of Q1 2026.
  • Clover Health Investments was a new Squarepoint position in Q1 2026.
  • Clover Health Investments made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #3961 holding.
  • Squarepoint first reported a position in Clover Health Investments in Q3 2020 and has held it in 17 quarters since.
  • Squarepoint's Clover Health Investments position peaked at $2.36M in Q1 2025.
  • 208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.